Moon Surgical's AI-Enhanced ScoPilot Gains FDA Clearance
Moon Surgical has received FDA clearance for its ScoPilot feature on the Maestro System, announced in a press release. ScoPilot, powered by NVIDIA Holoscan, is the first AI application to operate intraoperatively on a commercial surgical robotic platform. This feature allows surgeons to maintain control of the laparoscope without disengaging from their instruments, enhancing surgical flow and focus.
The Maestro System, which was FDA-cleared in June 2024, has been used in over 1,100 surgeries across the United States and Europe. It leverages NVIDIA-accelerated computing and AI to generate extensive surgical datasets, driving the development of next-generation Physical AI capabilities. Moon Surgical's collaboration with NVIDIA aims to further advance the Maestro System's AI capabilities through the NVIDIA Isaac for Healthcare platform, as detailed in a press release.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Robotics
Oct 16 Rareview and Tuttle Launch Humanoid Robotics ETF HOID Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 Launch Oct 16 RoboParty launches open source RP1 humanoid robot Oct 16 Jodell Robotics Unveils Dexterous Hand and Tactile Sensors Oct 16 Saab Completes Sea Trials of Large Uncrewed Underwater VehicleMore from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Market Logic Launches DeepSights MCP for AI Assistants
DeepSight Technology Adds Scott Huennekens to Board
MediSights Reports Study Using AI Agents for Myeloma Market Research
Andor Health Receives 2026 Frost & Sullivan Recognition for AI Care Orchestration
Daily AI Brief: the AI news that matters, in your inbox.